Healthequity, inc. (HQY)
Balance Sheet / Yearly
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Jul'14Jan'14
Assets
Current assets
Cash and cash equivalents

191,726

174,557

815,160

329,310

361,475

289,007

261,808

228,945

199,472

184,367

169,721

155,085

139,954

125,346

109,169

92,766

83,641

85,009

108,851

74,861

111,005

20,886

13,917

Marketable securities, at fair value

-

-

-

-

-

41,250

41,109

40,890

40,797

40,711

40,581

40,472

40,405

40,352

40,292

40,159

40,134

40,105

40,083

40,040

0

-

-

Total cash, cash equivalents and marketable securities

-

-

-

-

-

330,257

302,917

269,835

240,269

225,078

210,302

195,557

180,359

165,698

149,461

132,925

123,775

125,114

148,934

114,901

111,005

-

-

Accounts receivable, net of allowance for doubtful accounts of $1,216 and $125 as of January 31, 2020 and 2019, respectively

70,863

66,647

27,357

27,022

25,668

24,465

24,906

23,022

21,602

21,458

20,904

18,988

17,001

14,064

16,681

15,706

14,308

9,922

10,855

10,479

9,054

6,287

5,705

Inventories

-

-

-

-

-

164

163

177

-

169

339

529

592

944

699

598

620

815

590

667

625

369

391

Current deferred tax asset

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2,642

2,035

1,968

1,464

1,764

1,544

3,080

Other current assets

34,711

29,119

10,999

8,244

7,534

8,953

11,727

10,730

3,525

6,106

8,078

4,069

2,867

5,352

6,899

6,300

1,703

3,332

5,634

2,761

2,271

2,029

663

Total current assets

297,300

270,323

853,516

364,576

394,677

363,839

339,713

303,764

265,396

252,811

239,623

219,143

200,819

186,058

173,740

155,529

143,048

141,218

167,981

130,272

124,719

31,115

23,756

Investments

-

-

81,839

78,065

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,400

0

Property and equipment, net

33,486

35,199

9,873

8,481

8,223

8,743

8,869

8,626

7,836

6,789

6,080

6,083

5,170

5,373

4,251

3,388

3,506

3,614

3,157

3,079

2,577

2,549

1,992

Operating lease right-of-use assets

83,178

88,515

36,716

37,367

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

783,279

796,228

88,768

81,437

79,666

80,730

82,277

82,148

83,635

85,450

73,827

64,683

65,020

65,688

65,675

66,454

66,840

61,036

26,598

26,618

26,541

26,054

24,691

Goodwill

1,332,631

1,335,187

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

4,651

Deferred tax asset

18

0

666

551

1,677

1,435

1,038

616

5,461

4,656

5,054

6,438

1,615

696

505

345

0

-

-

-

-

-

-

Other assets

35,089

34,469

22,311

21,511

21,122

18,300

18,054

18,226

2,180

1,760

1,709

1,851

1,861

2,003

1,763

1,874

1,750

1,444

529

662

281

-

-

Total assets

2,564,981

2,559,921

1,098,340

596,639

510,016

477,698

454,602

418,031

369,159

356,117

330,944

302,849

279,136

264,469

250,585

232,241

219,795

211,963

202,916

165,282

158,769

65,769

55,090

Liabilities and stockholders’ equity
Current liabilities
Accounts payable

3,980

7,966

2,740

1,964

3,520

1,495

1,769

3,112

2,420

3,295

1,594

1,545

3,221

1,582

1,801

1,226

2,431

2,412

1,032

990

1,303

463

2,368

Accrued compensation

50,121

37,559

11,055

8,501

16,981

9,933

9,723

7,640

12,549

6,503

6,520

4,325

8,722

4,659

4,353

2,603

7,776

3,898

3,312

2,041

5,301

3,006

4,134

Accrued liabilities

46,372

54,305

19,392

9,127

8,552

5,972

5,577

6,402

5,521

9,680

4,829

4,435

3,760

4,195

2,782

3,146

1,899

3,053

2,861

2,153

2,227

2,755

2,927

Current portion of long-term debt

39,063

31,250

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

12,401

10,780

3,954

3,786

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series D-3 dividends payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

344

0

Total current liabilities

151,937

141,860

37,141

23,378

29,053

17,400

17,069

17,154

20,490

19,478

12,943

10,305

15,703

10,436

8,936

6,975

12,106

9,363

7,205

5,184

8,831

6,568

9,429

Long-term liabilities
Long-term debt, net of issuance costs

1,181,615

1,196,016

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, non-current

68,017

73,052

35,660

36,243

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

2,625

2,590

735

387

2,968

2,836

2,693

2,466

2,395

2,226

2,067

1,700

1,456

1,295

1,076

819

236

195

145

477

488

435

393

Deferred tax liability

130,492

128,642

7,773

7,332

916

661

2,221

1,437

0

0

0

0

37

149

1,114

1,711

3,996

4,080

4,405

5,053

5,355

5,389

5,078

Series D-3 redeemable convertible preferred stock derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

6,182

Total long-term liabilities

1,382,749

-

-

-

3,884

3,497

4,914

3,903

2,395

2,226

2,067

1,700

1,493

1,444

2,190

2,530

4,232

4,275

4,550

5,530

5,843

5,824

11,653

Total liabilities

1,534,686

1,542,160

81,309

67,340

32,937

20,897

21,983

21,057

22,885

21,704

15,010

12,005

17,196

11,880

11,126

9,505

16,338

13,638

11,755

10,714

14,674

12,392

21,082

Commitments and contingencies (see Note 7)

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Redeemable convertible preferred stock, $0.0001 par value, 26,473 shares authorized; 17,349 shares issued and outstanding as of July 31, 2014 and January 31, 2014; liquidation preference of $43,806 and $43,128 as of July 31, 2014 and January 31, 2014, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42,693

46,714

Stockholders’ equity
Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of January 31, 2020 and 2019

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

Common stock, $0.0001 par value, 900,000 shares authorized, 71,051 and 62,446 shares issued and outstanding as of January 31, 2020 and 2019, respectively

7

7

7

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

5

1

1

Common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21

2,334

Additional paid-in capital

818,774

806,050

783,986

315,621

305,223

298,064

289,568

276,440

261,237

255,245

247,255

238,953

232,114

226,794

219,648

211,185

199,940

197,905

194,794

162,611

157,094

20,301

0

Accumulated other comprehensive loss, net

-

-

-

-

-

0

0

0

-269

-188

-195

-191

-165

-134

-110

-137

-98

-67

-33

-22

0

-

-

Accumulated earnings

211,514

211,704

233,038

213,672

171,850

158,731

143,045

120,528

85,300

79,350

68,868

52,076

29,985

25,923

19,915

11,682

3,609

481

-3,606

-8,027

-13,004

-17,768

-23,170

Total stockholders’ equity

1,030,295

1,017,761

1,017,031

529,299

477,079

456,801

432,619

396,974

346,274

334,413

315,934

290,844

261,940

252,589

239,459

222,736

203,457

198,325

191,161

154,568

144,095

10,684

-12,706

Total liabilities and stockholders’ equity

2,564,981

2,559,921

1,098,340

596,639

510,016

477,698

454,602

418,031

369,159

356,117

330,944

302,849

279,136

264,469

250,585

232,241

219,795

211,963

202,916

165,282

158,769

65,769

55,090